FOXG1 dose tunes cell proliferation dynamics in human forebrain progenitor cells

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Heterozygous loss-of-function mutations in the Forkhead box G1 (FOXG1) gene are linked to microcephaly, seizures, and intellectual disability.
• Conversely, elevated FOXG1 expression is a common finding in glioblastoma, suggesting a role in cancer.

Purpose of the Study:

• To investigate the precise role of FOXG1 in human forebrain cell proliferation.
• To model FOXG1 syndrome and understand the impact of gene dosage on cellular functions.

Main Methods:

• Utilized cell models derived from individuals with clinically diagnosed FOXG1 syndrome and healthy controls.
• Employed genetic engineering techniques including loss-of-function, gene repair, and inducible expression systems.
• Analyzed cell cycle progression, proliferation rates, and primary cilia frequency.

Main Results:

• Cells with heterozygous FOXG1 loss exhibited significantly reduced proliferation and an increased G0/G1 cell cycle phase ratio.
• Increased primary cilia frequency was observed in cells with reduced FOXG1 levels.
• Engineered FOXG1 modulation confirmed a dose-dependent effect on cell proliferation, with gene repair restoring normal cellular phenotypes.

Conclusions:

• FOXG1 levels critically regulate human brain cell proliferation.
• The study establishes FOXG1's essential role in normal brain development and its dysregulation in disease states like glioblastoma.